- Joined
- 9 October 2009
- Messages
- 21,653
- Reaction score
- 13,079

Coronavirus: The 'unknown' Covid-19 deaths in rural India
Experts say the number of deaths is higher than what official data says in rural parts of India.

An Indian state has raised its COVID-19 death toll sharply higher after the discovery of thousands of unreported cases, lending weight to suspicion that India’s overall death tally is significantly more than the official figure.
Health experts say they believe both coronavirus infections and deaths are being significantly undercounted across the country partly because test facilities are rare in rural areas, where two-thirds of Indians live, and hospitals are few and far between.
Many people have fallen ill and died at home without being tested for the coronavirus.
The New York Times estimated deaths based on death counts over time and infection fatality rates and put India's toll at 600,000 to 1.6 million.
The government dismissed those estimates as exaggerated. But the main opposition Congress party said that other states must follow Bihar's example and conduct a review of deaths over the past two months
Also that’s the poorest in the world who will continue to pay the price of COVID-19.One thing that is often claimed, but attracts scientific scorn, is that the virus must get milder in order to spread more easily. There is very little evolutionary pressure on the virus for that to happen. The virus is already off into the next person long before it kills the person it infected. And the people who do the most spreading (younger people) are those who don't get very ill.
Covid: Is there a limit to how much worse variants can get? https://www.bbc.co.uk/news/health-57431420In rich countries with good vaccination campaigns it is hoped the next variants won't be able to pose a major problem due to widespread immunity. But these progressively more transmissible variants are a nightmare for the rest of the world where they are making it harder and harder to stay on top of Covid.
Yet again putting to bed one of the allegations of anti-vaxxers that health issues with these vaccines are covered up.![]()
CDC to hold ’emergency meeting’ on heart inflammation after COVID-19 vaccines
An advisory panel of the Centers for Disease Control and Prevention (CDC) will hold an emergency meeting on June 18 to discuss rare reports of heart inflammation after doses of COVID-19 vaccin…thehill.com
When Oxford University was searching for a partner for its vaccine, there was seemingly one natural choice: GlaxoSmithKline.
The £70.7bn drug maker was the world leader in vaccines and, importantly for the Government, it was British.
But, when Sir Patrick Vallance, the Government’s chief scientific adviser, made the call to his former colleague and GSK boss, Dame Emma Walmsley, he was turned down.
Now, more than a year later, Dame Emma may be regretting that decision.
Her refusal helped GSK avoid the attacks that were levelled at Oxford partner AstraZeneca, but employees within the company feel she was caught flat-footed.
“You don’t need to be a scientist, but you have to understand the industry and make those tough decisions,” says one insider. And in this case, they say, the decision was wrong.
The company’s failure to create a Covid vaccine has now become a symbol of what are believed to be bigger issues with Dame Emma’s leadership.
This is extremely good point. I mean do they have any Covid vaccines in development at all?![]()
Glaxo's vaccine failure leaves boss Emma Walmsley battling for survival
A failure to create a Covid vaccine has now become a symbol of what are believed to be bigger issues with Dame Emma’s leadershipwww.telegraph.co.uk
When Oxford University was searching for a partner for its vaccine, there was seemingly one natural choice: GlaxoSmithKline.
The £70.7bn drug maker was the world leader in vaccines and, importantly for the Government, it was British.
But, when Sir Patrick Vallance, the Government’s chief scientific adviser, made the call to his former colleague and GSK boss, Dame Emma Walmsley, he was turned down.
Now, more than a year later, Dame Emma may be regretting that decision.
Her refusal helped GSK avoid the attacks that were levelled at Oxford partner AstraZeneca, but employees within the company feel she was caught flat-footed.
“You don’t need to be a scientist, but you have to understand the industry and make those tough decisions,” says one insider. And in this case, they say, the decision was wrong.
The company’s failure to create a Covid vaccine has now become a symbol of what are believed to be bigger issues with Dame Emma’s leadership.
This is extremely good point. I mean do they have any Covid vaccines in development at all?![]()
Glaxo's vaccine failure leaves boss Emma Walmsley battling for survival
A failure to create a Covid vaccine has now become a symbol of what are believed to be bigger issues with Dame Emma’s leadershipwww.telegraph.co.uk
When Oxford University was searching for a partner for its vaccine, there was seemingly one natural choice: GlaxoSmithKline.
The £70.7bn drug maker was the world leader in vaccines and, importantly for the Government, it was British.
But, when Sir Patrick Vallance, the Government’s chief scientific adviser, made the call to his former colleague and GSK boss, Dame Emma Walmsley, he was turned down.
Now, more than a year later, Dame Emma may be regretting that decision.
Her refusal helped GSK avoid the attacks that were levelled at Oxford partner AstraZeneca, but employees within the company feel she was caught flat-footed.
“You don’t need to be a scientist, but you have to understand the industry and make those tough decisions,” says one insider. And in this case, they say, the decision was wrong.
The company’s failure to create a Covid vaccine has now become a symbol of what are believed to be bigger issues with Dame Emma’s leadership.
Aren't they teamed with Sanofi for the latter's second candidate? It does seem like a wasted opportunity though, since this collaboration will of course be a late-comer.
Further, I would once more note that the "attacks on AZ" were brought upon that company by its own poor performance. Unless you assume GSK would inevitably drop the ball in a similar manner, there's no reason whatsoever to expect them to come under the same sort of fire. And as the article mentions, being an established, major player in the vaccine market as opposed to AZ's inexperience, there are excellent grounds to believe they would have done better!
Vermont Gov. Phil Scott (R) announced Monday that 80% of its eligible population has received at least one dose of the COVID-19 vaccine.
Why it matters: Vermont is the first state in the country to reach that threshold. As a result, Scott said he is removing all COVID-19 restrictions.
The big picture: Vermont has led in vaccinations nationwide, and cases have been declining steadily in the state.
- As of June 14, Vermont's 14-day change in cases had declined by 34% and hospitalizations were down by 78%, according to the New York Times.
- 70% of adults in 12 U.S. states have received at least one shot as of June 2, according to CNBC. Overall, 64.4% of Americans nationwide have received at least one dose, according to the CDC.
WHO was prepared to accept 50% efficacy as the mark of a satisfactory vaccine, all of the approved vaccines are running well ahead of that. What's clear is that even in cases where the vaccine doesn't stop people getting infected, it does tend to lead to a less serious infection, meaning fewer admitted to hospital, fewer of those needing ventilation, and fewer of those dying.I don't think it's a good medicine when you vaccinate yourself on March and fell into the ill on June.![]()
The problem is that, along with the gold standard vaccine, they have a number of inferior versions as well.I don't think it's a good medicine when you vaccinate yourself on March and fell into the ill on June.